Showing 1 - 20 results of 33 for search 'Wen‐Cheng Chang', query time: 0.06s
Refine Results
-
1
Immune checkpoint inhibitors win the 2018 Nobel Prize by Pei-Wei Huang, John Wen-Cheng Chang
Published 2019-10-01
Article -
2
Hypernatremic Dehydration Due to Concentrated Infant Formula: Report of Two Cases by Cheung Leung, Wen-Cheng Chang, Shu-Jen Yeh
Published 2009-04-01
Article -
3
Radiation Recall Pneumonitis: A Rare Syndrome That Should Be Recognized by Pei-Rung Jan, John Wen-Cheng Chang, Chiao-En Wu
Published 2022-09-01
Article -
4
-
5
-
6
Taiwanese Dermatological Association consensus for the prevention and management of epidermal growth factor receptor tyrosine kinase inhibitor-related skin toxicities by Chia-Yu Chu, Kuan-Yu Chen, John Wen-Cheng Chang, Yu-Feng Wei, Chih-Hung Lee, Wei-Ming Wang
Published 2017-06-01
Article -
7
-
8
-
9
-
10
Prognostic and predictive factors for Taiwanese patients with advanced biliary tract cancer undergoing frontline chemotherapy with gemcitabine and cisplatin: a real-world experienc... by Chiao-En Wu, Wen-Chi Chou, Chia-Hsun Hsieh, John Wen-Cheng Chang, Cheng-Yu Lin, Chun-Nan Yeh, Jen-Shi Chen
Published 2020-05-01
Article -
11
-
12
-
13
Feasibility and effectiveness of afatinib for poor performance status patients with EGFR-mutation-positive non-small-cell lung cancer: a retrospective cohort study by Chiao-En Wu, Ching-Fu Chang, Chen-Yang Huang, Cheng-Ta Yang, Chih-Hsi Scott Kuo, Ping-Chih Hsu, John Wen-Cheng Chang
Published 2021-07-01
Article -
14
Comparison of Different Tyrosine Kinase Inhibitors for Treatment of Poor Performance Status Patients with EGFR-Mutated Lung Adenocarcinoma by Chiao-En Wu, Ching-Fu Chang, Chen-Yang Huang, Cheng-Ta Yang, Chih-Hsi Scott Kuo, Ping-Chih Hsu, John Wen-Cheng Chang
Published 2022-01-01
Article -
15
Distinct changes to pancreatic volume rather than pancreatic autoantibody positivity: insights into immune checkpoint inhibitors induced diabetes mellitus by Hung-Hui Wei, Ying-Chieh Lai, Gigin Lin, Cheng-Wei Lin, Ya-Chu Chang, John Wen-Cheng Chang, Miaw-Jene Liou, I-Wen Chen
Published 2024-01-01
Article -
16
-
17
Establishment of a Pretreatment Nomogram to Predict the 6-Month Mortality Rate of Patients with Advanced Biliary Tract Cancers Undergoing Gemcitabine-Based Chemotherapy by Chiao-En Wu, Wen-Kuan Huang, Wen-Chi Chou, Chia-Hsun Hsieh, John Wen-Cheng Chang, Cheng-Yu Lin, Chun-Nan Yeh, Jen-Shi Chen
Published 2021-06-01
Article -
18
-
19
Risk Stratification Using a Novel Nomogram for 2190 EGFR-Mutant NSCLC Patients Receiving the First or Second Generation EGFR-TKI by John Wen-Cheng Chang, Chen-Yang Huang, Yueh-Fu Fang, Ching-Fu Chang, Cheng-Ta Yang, Chih-Hsi Scott Kuo, Ping-Chih Hsu, Chiao-En Wu
Published 2022-02-01
Article -
20
The survival after discontinuation of EGFR‐TKIs due to intolerable adverse events in patients with EGFR‐mutated non–small cell lung cancer by John Wen‐Cheng Chang, Ching‐Fu Chang, Chen‐Yang Huang, Cheng‐Ta Yang, Chih‐Hsi Scott Kuo, Yueh‐Fu Fang, Ping‐Chih Hsu, Chiao‐En Wu
Published 2023-02-01
Article